Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PFAS-ITOX

Financiado

Developmental immunotoxicity of perfluoroalkyl substances (PFASs) in a populatio...

Developmental immunotoxicity of perfluoroalkyl substances (PFASs) in a population of highly-exposed children Exposures to perfluoroalkyl substances (PFASs), a class of persistent chemicals, have been linked to an array of adverse health outcomes including reduced antibody response to vaccination. The COVID-19 pandemic has focused attent... ver más

28/02/2025

LUNDS UNIVERSITET

223K€

Presupuesto del proyecto: 223K€

Líder del proyecto

LUNDS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-05-31

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021 ExpectedOutcome:

I+D

Cerrada hace 3 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

LUNDS UNIVERSITET

222.73K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EPIC Exploring the PFAS alternatives-induced immunotoxicity and i... 166K€ Cerrado

ENDOMIX Understanding how endocrine disruptors and chemical mixtures... 6M€ Cerrado

AGL2009-09061 EVALUACION DE LA TOXICIDAD NEUROENDOCRINA DE COMPUESTOS ORGA... 97K€ Cerrado

MANGO The chemical exposoMe of pregnAnt womeN with GestatiOnal dia... 261K€ Cerrado

PID2019-104443GB-I00 EXPOSICION TEMPRANA A SUSTANCIAS QUIMICAS A TRAVES DE MATERI... 97K€ Cerrado

PID2020-113812RB-C32 CONTAMINANTES AMBIENTALES, FENOTIPO AUTISTA Y ENVEJECIMIENTO 145K€ Cerrado

Duración del proyecto: 32 meses Fecha Inicio: 2022-05-31
Fecha Fin: 2025-02-28

Líder del proyecto

LUNDS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 223K€

Descripción del proyecto Exposures to perfluoroalkyl substances (PFASs), a class of persistent chemicals, have been linked to an array of adverse health outcomes including reduced antibody response to vaccination. The COVID-19 pandemic has focused attention on the serious implications of PFAS immunotoxicity. However, there is a lack of epidemiological studies on clinical immune outcomes (e.g., infections or asthma) in children, whose developing immune system is highly sensitive to chemical exposures. This proposal (PFAS-ITOX) addresses this research gap by leveraging a unique cohort of children with a wide range of PFAS exposures (background to highly exposed) and detailed medical records to investigate the potential immunotoxic effects of prenatal and childhood PFAS exposures on clinically relevant outcomes, including COVID-19 incidence. It was discovered in 2013 that one of two municipal water supplies in Ronneby, Sweden was delivering water that was highly contaminated by PFASs from firefighting foam runoff at a nearby military airport. Earlier studies in Ronneby found that serum PFAS concentrations corresponded closely with residential address history, allowing residential history to be used as an accurate proxy for exposure. PFAS-ITOX uses this natural experiment to create a longitudinal cohort of children and evaluate whether high PFAS exposures are associated with clinical outcomes related to immunosuppression (e.g., counts of common childhood infections) and hypersensitivity (e.g., incidence of asthma). While existing studies of PFAS immunotoxicity rely on self-reported data or hospital admission records, I will use the Skåne Healthcare Register, unique to southern Sweden, to identify outcomes at all levels of care, including primary care where many immune outcomes are diagnosed. The proposal's results will inform future PFAS research, provide necessary evidence for risk assessments, and provide critical information to health practitioners caring for highly-exposed individuals.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores